Logo image of HOLX

HOLOGIC INC (HOLX) Stock Fundamental Analysis

USA - NASDAQ:HOLX - US4364401012 - Common Stock

68.27 USD
+0.07 (+0.1%)
Last: 9/18/2025, 8:00:01 PM
68.25 USD
-0.02 (-0.03%)
After Hours: 9/18/2025, 8:00:01 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to HOLX. HOLX was compared to 191 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making HOLX a very profitable company, without any liquidiy or solvency issues. HOLX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

HOLX had positive earnings in the past year.
In the past year HOLX had a positive cash flow from operations.
Each year in the past 5 years HOLX has been profitable.
In the past 5 years HOLX always reported a positive cash flow from operatings.
HOLX Yearly Net Income VS EBIT VS OCF VS FCFHOLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

HOLX has a better Return On Assets (6.33%) than 85.86% of its industry peers.
With an excellent Return On Equity value of 11.50%, HOLX belongs to the best of the industry, outperforming 88.48% of the companies in the same industry.
HOLX has a better Return On Invested Capital (10.03%) than 91.10% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HOLX is above the industry average of 8.46%.
Industry RankSector Rank
ROA 6.33%
ROE 11.5%
ROIC 10.03%
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
HOLX Yearly ROA, ROE, ROICHOLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

HOLX has a Profit Margin of 13.79%. This is amongst the best in the industry. HOLX outperforms 91.10% of its industry peers.
In the last couple of years the Profit Margin of HOLX has declined.
The Operating Margin of HOLX (24.55%) is better than 94.24% of its industry peers.
In the last couple of years the Operating Margin of HOLX has grown nicely.
HOLX has a Gross Margin of 56.34%. This is comparable to the rest of the industry: HOLX outperforms 53.93% of its industry peers.
HOLX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.55%
PM (TTM) 13.79%
GM 56.34%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
HOLX Yearly Profit, Operating, Gross MarginsHOLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HOLX is still creating some value.
HOLX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HOLX has been reduced compared to 5 years ago.
HOLX has a better debt/assets ratio than last year.
HOLX Yearly Shares OutstandingHOLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
HOLX Yearly Total Debt VS Total AssetsHOLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

HOLX has an Altman-Z score of 3.97. This indicates that HOLX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HOLX (3.97) is better than 74.35% of its industry peers.
HOLX has a debt to FCF ratio of 2.75. This is a good value and a sign of high solvency as HOLX would need 2.75 years to pay back of all of its debts.
HOLX's Debt to FCF ratio of 2.75 is amongst the best of the industry. HOLX outperforms 87.43% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that HOLX is somewhat dependend on debt financing.
HOLX has a Debt to Equity ratio of 0.52. This is in the lower half of the industry: HOLX underperforms 61.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 2.75
Altman-Z 3.97
ROIC/WACC1.27
WACC7.91%
HOLX Yearly LT Debt VS Equity VS FCFHOLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 3.55 indicates that HOLX has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.55, HOLX is doing good in the industry, outperforming 65.44% of the companies in the same industry.
A Quick Ratio of 2.81 indicates that HOLX has no problem at all paying its short term obligations.
HOLX has a Quick ratio of 2.81. This is in the better half of the industry: HOLX outperforms 65.97% of its industry peers.
Industry RankSector Rank
Current Ratio 3.55
Quick Ratio 2.81
HOLX Yearly Current Assets VS Current LiabilitesHOLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

4

3. Growth

3.1 Past

HOLX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.80%.
Measured over the past years, HOLX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.83% on average per year.
Looking at the last year, HOLX shows a small growth in Revenue. The Revenue has grown by 1.29% in the last year.
Measured over the past years, HOLX shows a small growth in Revenue. The Revenue has been growing by 3.66% on average per year.
EPS 1Y (TTM)4.8%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%1.89%
Revenue 1Y (TTM)1.29%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%1.23%

3.2 Future

Based on estimates for the next years, HOLX will show a small growth in Earnings Per Share. The EPS will grow by 7.42% on average per year.
The Revenue is expected to grow by 4.28% on average over the next years.
EPS Next Y6.02%
EPS Next 2Y6.33%
EPS Next 3Y7.49%
EPS Next 5Y7.42%
Revenue Next Year1.61%
Revenue Next 2Y3.03%
Revenue Next 3Y3.75%
Revenue Next 5Y4.28%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HOLX Yearly Revenue VS EstimatesHOLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
HOLX Yearly EPS VS EstimatesHOLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.45, which indicates a correct valuation of HOLX.
Based on the Price/Earnings ratio, HOLX is valued cheaper than 85.34% of the companies in the same industry.
HOLX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.41.
Based on the Price/Forward Earnings ratio of 14.80, the valuation of HOLX can be described as correct.
Based on the Price/Forward Earnings ratio, HOLX is valued cheaply inside the industry as 85.86% of the companies are valued more expensively.
HOLX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.88.
Industry RankSector Rank
PE 16.45
Fwd PE 14.8
HOLX Price Earnings VS Forward Price EarningsHOLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HOLX is valued cheaper than 86.39% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 90.05% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.56
EV/EBITDA 12.18
HOLX Per share dataHOLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)2.73
PEG (5Y)1.52
EPS Next 2Y6.33%
EPS Next 3Y7.49%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HOLX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HOLOGIC INC

NASDAQ:HOLX (9/18/2025, 8:00:01 PM)

After market: 68.25 -0.02 (-0.03%)

68.27

+0.07 (+0.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners105%
Inst Owner Change-0.75%
Ins Owners0.78%
Ins Owner Change0.04%
Market Cap15.18B
Analysts73.57
Price Target74.47 (9.08%)
Short Float %1.42%
Short Ratio1.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.06%
Min EPS beat(2)-0.63%
Max EPS beat(2)0.76%
EPS beat(4)1
Avg EPS beat(4)-0.69%
Min EPS beat(4)-2.26%
Max EPS beat(4)0.76%
EPS beat(8)5
Avg EPS beat(8)0.96%
EPS beat(12)9
Avg EPS beat(12)5.99%
EPS beat(16)13
Avg EPS beat(16)15.79%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)-0.21%
Revenue beat(4)0
Avg Revenue beat(4)-1.18%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.21%
Revenue beat(8)1
Avg Revenue beat(8)-0.83%
Revenue beat(12)5
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)4.67%
PT rev (1m)2.34%
PT rev (3m)9.06%
EPS NQ rev (1m)0.55%
EPS NQ rev (3m)2.67%
EPS NY rev (1m)1.42%
EPS NY rev (3m)1.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE 16.45
Fwd PE 14.8
P/S 3.76
P/FCF 16.56
P/OCF 14.2
P/B 3.14
P/tB 27.29
EV/EBITDA 12.18
EPS(TTM)4.15
EY6.08%
EPS(NY)4.61
Fwd EY6.76%
FCF(TTM)4.12
FCFY6.04%
OCF(TTM)4.81
OCFY7.04%
SpS18.16
BVpS21.77
TBVpS2.5
PEG (NY)2.73
PEG (5Y)1.52
Profitability
Industry RankSector Rank
ROA 6.33%
ROE 11.5%
ROCE 12.64%
ROIC 10.03%
ROICexc 13.19%
ROICexgc 46.87%
OM 24.55%
PM (TTM) 13.79%
GM 56.34%
FCFM 22.7%
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 2.75
Debt/EBITDA 1.96
Cap/Depr 51.64%
Cap/Sales 3.77%
Interest Coverage 250
Cash Conversion 83.11%
Profit Quality 164.55%
Current Ratio 3.55
Quick Ratio 2.81
Altman-Z 3.97
F-Score6
WACC7.91%
ROIC/WACC1.27
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)4.8%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%1.89%
EPS Next Y6.02%
EPS Next 2Y6.33%
EPS Next 3Y7.49%
EPS Next 5Y7.42%
Revenue 1Y (TTM)1.29%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%1.23%
Revenue Next Year1.61%
Revenue Next 2Y3.03%
Revenue Next 3Y3.75%
Revenue Next 5Y4.28%
EBIT growth 1Y7.45%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year13.14%
EBIT Next 3Y7.97%
EBIT Next 5Y7.8%
FCF growth 1Y10.21%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y11.23%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%